| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $22.7M | +27.7% |
| SG&A Expense | $7.2M | -0.9% |
| Operating Income | -$29.9M | -19.3% |
| Income Tax | $0 | — |
| Net Income | -$26.7M | -11.5% |
| EPS (Basic) | -$0.46 | +69.3% |
| EPS (Diluted) | -$0.46 | +69.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $94.4M | +553.5% |
| Current Assets | $97.9M | +510.0% |
| Total Assets | $98.1M | +510.9% |
| Current Liabilities | $2.7M | -34.4% |
| Total Liabilities | $2.9M | -31.8% |
| Stockholders' Equity | $95.3M | +702.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.6M | +30.8% |
| Capital Expenditures | $7K | — |
| Investing Cash Flow | -$14.8M | — |
| Financing Cash Flow | $109.3M | — |
| Free Cash Flow | -$14.6M | +30.8% |